ストックスクリーナーアプリを入手
199.08
1.31%
-2.64
アフターアワーズ：
199.08
前日終値:
$201.72
開ける：
$202.65
24時間の取引高:
490.53K
Relative Volume:
0.40
時価総額：
$16.44B
収益：
$8.31B
当期純損益:
$747.89M
株価収益率:
22.19
EPS:
8.97
ネットキャッシュフロー:
$1.23B
1週間 パフォーマンス:
-0.70%
1か月 パフォーマンス:
-5.07%
6か月 パフォーマンス:
-39.39%
1年 パフォーマンス:
-23.69%
1日の値動き範囲:
$198.64
$204.33
1週間の範囲:
$194.33
$206.60
52週間の値動き範囲:
$183.38
$347.72
Icon Plc Stock (ICLR) Company Profile
ICLR を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ICLR
Icon Plc
|
199.08 | 16.44B | 8.31B | 747.89M | 1.23B | 8.97 |
|
TMO
Thermo Fisher Scientific Inc
|
597.75 | 228.64B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
222.74 | 160.17B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
151.52 | 43.27B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
201.36 | 36.55B | 15.32B | 1.41B | 1.96B | 7.62 |
|
IDXX
Idexx Laboratories Inc
|
422.05 | 34.56B | 3.84B | 866.24M | 792.60M | 10.37 |
Icon Plc Stock (ICLR) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-10-24 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-10-14 | 開始されました | Redburn Atlantic | Neutral |
| 2024-09-18 | 開始されました | Leerink Partners | Outperform |
| 2024-06-06 | 開始されました | Goldman | Buy |
| 2023-12-15 | 開始されました | Truist | Buy |
| 2023-09-13 | 開始されました | TD Cowen | Outperform |
| 2023-01-17 | アップグレード | Barclays | Equal Weight → Overweight |
| 2023-01-13 | アップグレード | Barclays | Equal Weight → Overweight |
| 2022-11-09 | アップグレード | BofA Securities | Neutral → Buy |
| 2022-09-07 | 開始されました | UBS | Buy |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-05-24 | 開始されました | Guggenheim | Buy |
| 2022-04-25 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2022-04-12 | アップグレード | Deutsche Bank | Hold → Buy |
| 2021-09-27 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-23 | アップグレード | Citigroup | Neutral → Buy |
| 2021-07-14 | 開始されました | Citigroup | Neutral |
| 2021-04-13 | 再開されました | BofA Securities | Neutral |
| 2021-04-01 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-03-08 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2021-03-03 | 開始されました | Barclays | Equal Weight |
| 2021-03-01 | アップグレード | UBS | Neutral → Buy |
| 2021-02-26 | アップグレード | Truist | Hold → Buy |
| 2020-07-24 | ダウングレード | BofA Securities | Buy → Neutral |
| 2020-04-20 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2020-03-26 | アップグレード | Barclays | Equal Weight → Overweight |
| 2020-03-02 | 開始されました | Deutsche Bank | Hold |
| 2020-01-27 | ダウングレード | SunTrust | Buy → Hold |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Neutral |
| 2019-09-23 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2019-07-26 | アップグレード | UBS | Sell → Neutral |
| 2019-01-25 | アップグレード | Mizuho | Neutral → Buy |
| 2018-10-26 | アップグレード | Evercore ISI | In-line → Outperform |
| 2018-10-09 | 開始されました | UBS | Sell |
| 2018-04-03 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2018-02-15 | 繰り返されました | Mizuho | Neutral |
| 2018-01-19 | 開始されました | Evercore ISI | Outperform |
| 2017-10-27 | 繰り返されました | Barclays | Equal Weight |
| 2017-09-11 | 開始されました | BofA/Merrill | Buy |
| 2017-07-31 | アップグレード | SunTrust | Hold → Buy |
| 2017-07-27 | 繰り返されました | Mizuho | Neutral |
| 2017-06-29 | アップグレード | Jefferies | Hold → Buy |
すべてを表示
Icon Plc (ICLR) 最新ニュース
Precision neuropsychiatry spotlight: a BioCentury podcast - BioCentury
ICON discovers over £10,000 of energy savings following audit by Green Zone Surveys - The Energyst
ICON plc (ICLR): Revolutionizing Clinical Trials with AI Innovations - Yahoo Finance
ICON Portfolio of AI Tools Drives Clinical Trial Efficiencies - sharewise
ICON plc Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call - sharewise
ICON plc to Announce 2024 Financial Results in February 2025 - TipRanks
Clinical Research Giant ICON Announces Critical Q4 Results Timeline - StockTitan
TD Cowen cuts ICON stock price target to $254, maintains Buy rating - MSN
Contract Clinical Research Organization Market Set to Witness Significant Growth by 2025-2032:ICON plc, - EIN News
Europe Pharmacovigilance and Drug Safety Software Market Forecast, Regional Share and Growth Opportunity Analysis to 2031 - GlobeNewswire Inc.
ICON Public (ICLR) Stock Price, News & Analysis - MarketBeat
Arkadios Wealth Advisors Lowers Stock Holdings in ICON Public Limited (NASDAQ:ICLR) - Defense World
Healthcare Contract Research Outsourcing Market Projected To Witness Substantial Growth, 2025-2032: ICON plc, - EIN News
eClinical Solutions Market Key Players AnalysisIcon Plc, - openPR
RBC Capital Initiates Coverage of ICON Public Limited (ICLR) with Outperform Recommendation - MSN
Icon (ICLR) 3-Year EPS without NRI Growth Rate : 8.70% (As of Sep. 2024) - GuruFocus.com
Icon PLC (ICLR) Beats Q1 Earnings and Revenue Estimates - MSN
Icon sees FY25 adjusted EPS $13.00-$15.00, consensus $14.93 - Yahoo Finance
Icon PLC (ICLR) Stock Price Down 6.6% on Jan 14 - GuruFocus.com
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty - Benzinga
ICON plc stock retains Overweight rating amid conservative growth forecasts - Investing.com India
ICON plc stock retains Overweight rating amid conservative growth forecasts By Investing.com - Investing.com Australia
ICON Issues Financial Guidance for Full Year 2025 - sharewise
ICON plc Announces 2025 Financial Guidance Amid Market Challenges - TipRanks
Decentralized Clinical Trials Market Recent Growth: Market - openPR
ICON Public (NASDAQ:ICLR) Earns Outperform Rating from Analysts at Royal Bank of Canada - Defense World
ICON Survey: 97% Use Biomarkers in Neurodegenerative Trials, But Innovation Gaps Persist - StockTitan
ICON's SWOT analysis: CRO giant faces headwinds amid long-term growth potential - Investing.com India
ICON plc draws bullish views at RBC on attractive valuation - MSN
Icon PLC (ICLR) Stock Price Up 4.66% on Jan 7 - GuruFocus.com
ICON plc to Present at the 43rd Annual J.P. Morgan Healthcare Conference - BioSpace
ICON plc to Present at the J.P. Morgan Healthcare Conference - TipRanks
Outperform rating on ICON stock highlights potential for valuation re-rating in 2025 - Investing.com
Why Icon Plc Shares Face Rocky Times Ahead - TipRanks
ICON Properties Plc (ICON.mw) Q42024 Interim Report - AfricanFinancials
ICON Clinches TIME Magazine's Top CRO Ranking, Dominates Industry Awards in 2024 - StockTitan
ICON and Its Employees Celebrated for Excellence in the Field of Clinical Research - Silicon Canals
ICON appoints Barry Balfe as COO - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages ICON Public Limited Company (ICLR) Shareholders to Inquire about Securities Investigation - AccessWire
Bioanalytical Services Market Key Players AnalysisPPD, Inc., - openPR
ICON plc appoints Barry Balfe as new COO By Investing.com - Investing.com Australia
ICON plc Appoints Barry Balfe as Chief Operating Officer - TipRanks
ICON plc appoints Barry Balfe as new COO - Investing.com
ICON Appoints 20-Year Veteran Barry Balfe as Chief Operating Officer to Drive Strategic Growth - StockTitan
Truist cuts ICON price target to reflect company commentary - Investing.com
ICON's SWOT analysis: CRO giant navigates turbulent market - Investing.com
October 2025 Options Now Available For Icon - Nasdaq
Contract Research Organization Services Market Set to Witness Significant Growth by 2024-2031: IQVIA, LabCorp, - EIN News
Icon Plc (ICLR) 財務データ
収益
当期純利益
現金流量
EPS
0.69%
0.37%
大文字化:
|
ボリューム (24 時間):